The potentially protective role of adiponectin was demonstrated in a study with 133 patients with first-ever ischaemic stroke, where circulating levels of adiponectin were inversely associated with the prevalence of cerebral microbleeds after adjusting for age, sex and cardiovascular risk factors [37]. Here, ADIPOQ is linked to cerebral microbleeds.